MP

Molecular Pharmaceutics

Molecular Pharmaceutics publishes findings on the molecular mechanistic understanding of drug delivery and drug delivery systems.

Looking to publish in Molecular Pharmaceutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Medicine, Research & Experimental, Pharmacology & Pharmacy
Impact Factor 4.5
Quartile Q2
Open Access Type Hybrid
ISSN 1543-8384
eISSN 1543-8392
Invitation Only No
Cost Range No fees for authors under eligible institutional read and publish agreements; read and green agreements may include APC discounts for full open access upgrades.

Submission Instructions

Molecular Pharmaceutics accepts the following article types. Click on an article type to view submission instructions.

Review

Cover Letter Cover Letter requirements are not specified.
Abstract A brief anticipated abstract must be included in the review proposal. Abstract must typically be 150–300 words maximum.
Manuscript Review proposals must be submitted as a single document. The submission must include a proposed title, names and affiliations and websites of corresponding authors, a summary of the authors’ expertise supported by related publications, and a statement explaining how the proposed review differs from recent reviews or perspectives on the topic.
References The review proposal must include 5–10 key references that may form the foundation of the manuscript.
Figures & Tables Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance.
Reformat to Molecular Pharmaceutics using Livewrite Premium

Research Articles

Cover Letter A cover letter must accompany every manuscript submission.
Abstract An abstract is required for Research Articles. Abstract must typically be 150–300 words maximum. Abstract should be unstructured.
Manuscript Manuscript must use clearly identified standard sections for original research, including an Introduction, an Experimental Section, and a single-paragraph Conclusions section. Manuscript must include a graphical summary for the table of contents, 5–6 significant keywords after the abstract, and any AI-use disclosure in the Acknowledgments or Methods as appropriate.
References References and notes must be numbered consecutively in order of mention and cited in the text with superscript numbers, and titles must be included for initial submission.
Figures & Tables Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance, while Supporting Information must be submitted as separate files. Each figure must have a caption below it and each table must have a brief title describing its contents.
Reformat to Molecular Pharmaceutics using Livewrite Premium

Communication

Cover Letter A cover letter must accompany the submission.
Abstract An abstract is required. Abstract must be less than 100 words.
Manuscript Communications are generally limited to five journal pages. Initial submission must use clearly identified standard sections for reporting original research. Manuscript must include a graphical summary for the table of contents and 5–6 significant keywords after the abstract.
References Communications may contain up to 50 references. References must be numbered consecutively in order of mention in the text and cited with superscript numbers.
Figures & Tables Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance. Each figure must have a caption below it, and each table must have a brief title describing its contents.
Reformat to Molecular Pharmaceutics using Livewrite Premium

Recent Publications

64 Cu-Labeled Bioorthogonal Probe for Targeted Positron Emission Tomography Imaging of Malignant Melanoma

Boreum Song, Dagyeong Hong, Chaewon Lee, Yejin Seo, Eunsu Kim, Wookyeong Jeong, Seyeon Choi, Chang Sup Lee, Seong-Young Kwon, Dong-Yeon Kim, Ayoung Pyo

10.1021/acs.molpharmaceut.6c00247
View Publication

Reversible & Microbubble Concentration-Dependent Permeabilization of an In Vitro Human Endothelial Barrier to Small Molecules Using Ultrasound: Implications for Neurodegenerative Diseases Therapy

Karen Ea, Margot Pinaud, Damien Fouan, Antoine Presset, Jean-Yves Tartu, Noboru Sasaki, Nicolas Taulier, Wladimir Urbach, Christiane Contino-Pépin, Stéphane Desgranges, Hélène Blasco, Philippe Corcia, Patrick Vourc’h, Jean-Michel Escoffre

10.1021/acs.molpharmaceut.6c00168
View Publication

PET Imaging Characterization of Sphingosine-1-Phosphate Receptor 2 in a Mouse Model of Esophageal Adenocarcinoma and Metastatic Lymph Node

Hong Chen, Lin Qiu, Wenjuan Zhou, Hao Jiang, Shuxian Xu, Sandip B. Jadhav, Anil Kumar Soda, Guangyong Peng, Zibo Li, Robert J. Gropler, Zhude Tu

10.1021/acs.molpharmaceut.6c00366
View Publication

Enhanced Therapeutic Efficacy of Combined Photothermal Therapy and Doxorubicin Chemotherapy in Anaplastic Thyroid Carcinoma: An Innovative Treatment Approach

Fan Yang, Yili Zhou, Yi Xu, Hongzhong Zhou, Jinmiao Qu, Hongwei Sun, Shixu Lv

10.1021/acs.molpharmaceut.5c01894
View Publication

Pharmacokinetics and Dosimetry of 177 Lu-DOTATATE in Patients with Advanced Well-Differentiated, Gastroenteropancreatic Neuroendocrine Tumors: Results from a Substudy of the Phase 3 XT-XTR008-3-01 Trial

Guangyu Ma, Yanliang Dong, Shuwei Sun, Yuan Wang, Huijuan Ji, Xiaodan Xu, Qiaoying Yang, Yabing Sun, Hui Zhou, Xiaojun Zhang, Ting Ye, Ang Yin, Ruimin Wang

10.1021/acs.molpharmaceut.6c00126
View Publication

Frequently asked questions

How long does it take to publish?

Significant delays in the peer review process can occur if crystallographic information files are not submitted in advance.

Reformat to Molecular Pharmaceutics using Livewrite Premium

Is a cover letter required?

A cover letter must accompany every manuscript submission. It should state the innovation or novelty of the manuscript and provide the name and email address of the corresponding author. Revised manuscripts should include a cover letter describing the changes and revisions. Preprint use should be noted in the cover letter. Crystal structure submissions should notify the editor in the cover letter that structural data accompanies the manuscript.

Reformat to Molecular Pharmaceutics using Livewrite Premium

What are the publication costs?

No fees for authors under eligible institutional read and publish agreements; read and green agreements may include APC discounts for full open access upgrades.

Reformat to Molecular Pharmaceutics using Livewrite Premium

Research Topics

RNA Interference and Gene Delivery Nanoparticle-Based Drug Delivery Drug Solubulity and Delivery Systems Drug Transport and Resistance Mechanisms Nanoplatforms for cancer theranostics Advanced Drug Delivery Systems Advanced biosensing and bioanalysis techniques Crystallization and Solubility Studies Monoclonal and Polyclonal Antibodies Research Protein purification and stability Radiopharmaceutical Chemistry and Applications Analytical Chemistry and Chromatography Peptidase Inhibition and Analysis Computational Drug Discovery Methods Immunotherapy and Immune Responses Advancements in Transdermal Drug Delivery Lipid Membrane Structure and Behavior Dendrimers and Hyperbranched Polymers Virus-based gene therapy research Crystallography and molecular interactions Inhalation and Respiratory Drug Delivery Pharmacological Effects and Toxicity Studies Pharmacogenetics and Drug Metabolism Glycosylation and Glycoproteins Research Surfactants and Colloidal Systems

Related Journals

B&
Biomedicine & Pharmacotherapy Elsevier BV
DD
Drug Design Development And Therapy Dove Medical Press
CP
Clinical Pharmacology & Therapeutics WILEY
Va
Vaccines Multidisciplinary Digital Publishing Institute
ER
Expert Reviews In Molecular Medicine Cambridge University Press
MT
Molecular Therapy Elsevier BV